
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ING2 CRISPR/Cas9 KO Plasmid (h) | sc-404193 | 20 µg | $397.00 |
ING2 (inhibitor of growth family member 2) is a nuclear tumor suppressor–associated protein that functions as a chromatin reader through its C-terminal PHD finger, recognizing H3K4me3 and coordinating transcriptional programs linked to DNA damage signaling and cell-cycle control. It participates in epigenetic regulation by engaging histone acetyltransferase/deacetylase complexes and modulating p53-dependent stress responses, thereby influencing apoptosis, senescence, and genome stability. ING2 has been connected to pathways controlling chromatin accessibility and repair factor recruitment following genotoxic stress. Altered ING2 expression or function has been reported in multiple cancer contexts and is studied for its contributions to oncogenic transformation, metastatic potential, and therapy resistance mechanisms at the molecular level.
ING2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the ING2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the ING2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the ING2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ING2 protein expression.
This CRISPR knockout system enables efficient generation of ING2-deficient cell models for investigation of ING2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.